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Consumption of high v-3 fatty acid diet suppressed prostate tumorigenesis in C3(1)
Tag mice
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Prostate cancer incidence and mortality are high in the Western
world and high v-6/v-3 PUFA in the Western diet may be a con-
tributing factor. We investigated whether changing from a diet
that approximates v-6 fat content of the Western diet to a high
v-3 fat diet at adulthood might reduce prostate cancer risk. Fe-
male SV 129 mice that had consumed a high v-6 diet containing
corn oil for 2 weeks were bred with homozygous C3(1)Tag trans-
genic male mice. All male offspring were weaned to the corn oil
diet (CO) until postpuberty when half of the male offspring were
transferred to a high v-3 diet containing canola oil and fish oil
concentrate (FS). High v-3 diet increased v-3 and decreased v-6
fat content of mice tissues. Average weights of prostate and gen-
itourinary bloc were significantly lower in mice consuming high
v-3 diet at adulthood (CO-FS) than mice fed a lifetime high v-6
diet (CO–CO). There was slower progression of tumorigenesis
in dorsalateral prostate of CO-FS than in CO–CO mice. CO-
FS mice had slightly lower plasma testosterone level at 24 and
40 weeks, significantly lower estradiol level at 40 weeks and sig-
nificantly less expressed androgen receptor (AR) in the dorsalat-
eral prostate at 40 weeks than CO–COmice. Consumption of high
v-3 diet lowered the expression of genes expected to increase
proliferation and decrease apoptosis in dorsalateral prostate.
Our results suggest that consumption of high v-3 diet slows down
prostate tumorigenesis by lowering estradiol, testosterone and AR
levels, promoting apoptosis and suppressing cell proliferation in
C3(1)Tag mice.
Introduction
Prostate cancer has remained the most frequently diagnosed cancer
and the second leading cause of cancer related death among men in the
USA, accounting for 28% of total expected cancer incidence in men of
USA in 2010 (1). In general, the incidence and mortality of prostate
cancer are high in North America and Northern Europe but much
lower in Japan and other Asian countries (2). Migration studies show
that Asian men living in the USA have a lower risk of prostate cancer
than the Caucasians but have a higher risk than their counterparts
living in Asia (3). Japanese men that immigrate to the USA die of
prostate cancer with increasing frequency as a function of the num-
ber of years of their residency (4). The major factor for this in-
creased frequency in prostate cancer death is thought to be the
Western diet.
Polyunsaturated fatty acids (PUFA) are a component of dietary fat
reported from several investigations to influence the development of
prostate cancer (5). In the past 100 years, the fatty acid composition
of Western diets has witnessed a dramatic change, largely due to
a high increase in the consumption of omega-6 (x-6) PUFA from
vegetable oils and red meat and less consumption of omega-3 (x-3)
PUFA (6). This has resulted in an x-6/x-3 ratio of 25:1 to 40:1 rather
than near the ideal 1:1 in the US diets. Asian diets are lower in x-6
and higher in x-3 than the Western diet due to more consumption of
fish and other sea products and low consumption of plant oils and
red meat.
Several studies have investigated the effects of x-3 and x-6 fat on
prostate tumor cells. Omega-3 PUFA [eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA)] inhibit tumor cell growth in animal
models and human prostate cell lines (7,8), whereas x-6 PUFA [lino-
leic acid (LA) and arachidonic acid (AA)] increase growth of human
prostate tumor cell lines (7,9). Epidemiologic studies also reported
a decrease of metastatic prostate cancer risk and prostate cancer death
in men who consume the most fish (10–13), a good source of EPA and
DHA. LA is the most abundant x-6 PUFA in the human diet. It is
abundant in many plant oils such as corn oil, safflower oil and sun-
flower oil. LA is the precursor for the synthesis of AA, which is
abundant in red meat and meat fat.
Prostate cancer burden continues to increase because of the aging
and growing population as well as nutritional patterns that tend to
increase the risk for the disease. There is the need to identify and
establish factors that might prevent or slow the progression of prostate
cancer. If beneficial, a dietary change that includes the reduction in the
intake of x-6 PUFA and increase the proportion of dietary x-3 PUFA
may therefore be a powerful tool for prevention of mortality from
prostate cancer.
In this study, we tested the hypothesis that compared with a diet that
approximates the x-6 fatty acid content of the Western diet exposure
to a diet with more x-3 fatty acids during adulthood will slow the
progression of prostate cancer and to identify the underlying molec-
ular factors. The C3(1)Tag mouse was used for the study because it
develops prostate cancer slowly and has a well-characterized disease
progression making it suitable for prevention studies (14). We show
that compared with a diet that is high in x-6/x-3 fat, consumption of
low x-6/x-3 diet slows prostate carcinogenesis.
Materials and methods
Mice
Twenty female SV 129 mice, at 6 weeks of age, were obtained from Charles
River Laboratories (Wilmington, MA), quarantined for 2 weeks and transferred
to a study room. Mice that bear a transgene for the SV40 large T antigen with
a C3(1) rat prostatic steroid-binding protein promoter were obtained from
Dr Jeffrey Green for breeding. The C3(1)Tag mouse model was developed
in the laboratory of Dr Jeffrey E.Green of the National Cancer Institute. The
male transgenic mice develop prostatic intraepithelial neoplasia (PIN) that
progresses to prostate carcinoma due to expression of the large T antigen in
the prostate (14). All mice were genotyped to confirm the presence of the
transgene.
Abbreviations: AA, arachidonic acid; ADC, adenocarcinoma; AR, androgen
receptor; EPA, eicosapentaenoic acid; DHA, docosahexaenoic acid; DL, dor-
solateral prostate; HGPIN, high-grade prostatic intraepithelial lesion; GU,
genitourinary; LA, linoleic acid; LGPIN, low-grade prostatic intraepithelial
neoplasia; NOS, nitric oxide synthase; PCR, polymerase chain reaction;
PIN, prostatic intraepithelial neoplasia; PCNA, proliferating cell nuclear anti-
gen; PUFA, polyunsaturated fatty acid.
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Study design and feeding
All female SV 129 mice were placed on a diet containing 10% wt/wt corn oil
(high x-6, control diet, ratio of x-6/x-3 was 50). After 2 weeks, they were bred
with homozygous C3(1) Tag transgenic male mice. All male hemizygous off-
spring were weaned to the corn oil diet (CO) and consumed this diet until the
postpuberty age of 7 weeks. Half of the offspring were retained on the corn oil
diet to generate the high x-6 CO–CO (mother—pup diet) group, whereas the
remaining half were transferred to a higher x-3 diet [(FO), test diet] to generate
the CO-FS (mother—pup diet) group. The high x-3 diet contained 5% canola
oil (to provide adequate essential x-6 fatty acid) and 5% fish oil concentrate
(ratio of x-6/x-3 in the diet was 0.3). The offspring were housed not more than
four in a cage, numbered for individual identification and weighed weekly. All
animals were maintained in an isolated environment in barrier cages and fed
the specified diet. Mice were fed ad libitum with fresh food 6 days per week
and any leftover food in the cages was discarded.
The animal protocol was approved by the Marshall University school of
Medicine Institutional Animal Care and Use Committee.
Diet
Diets were prepared in the animal diet prep room of Marshall University
School of Medicine, using an AIN-76-A rodent diet modified to contain
10% total fat (Supplementary Table I is available at Carcinogenesis Online).
The AIN-76-A diet is adequate for the supply of nutrition and growth of the
mice (15). The control and test diets were isocaloric and isonutrient and are
relevant to human consumption. Casein, corn starch and other dry ingredients
for the diets (except sugar) were obtained from MP Biomedicals (Solon, Ohio),
fish oil concentrate (containing 60% EPA þ DHA) (Supplementary Table II is
available at Carcinogenesis Online) were obtained from Zone Labs (Danvers,
MA), whereas sugar and oil (100% canola oil or 100% corn oil) were obtained
locally. Diets were prepared in batches as needed and stored in sealed contain-
ers at 20C to prevent bacterial growth and fat oxidation in the food.
Assessment of transgene expression
Ear punches stored at 20C were digested as described previously (16) and
assessed for the presence of SV40 Tag transgene by real time polymerase chain
reaction (PCR) method, using an ABI Prism 7000 instrument (Applied
Biosystems, Foster City, CA).
Body weights
To assess the effect of diet on body weight, mice body weights were recorded
weekly and terminally during dissection.
Dissection and tissue collection
Mice were euthanized at 24 and 40 weeks of age. A 24-week time point was
chosen as adequate time for early-stage disease progression in our heterozygote
mice since previous studies indicated that C3(1)Tag male mice develop high-
grade prostatic intraepithelial lesion (HGPIN) at 20 weeks (14). PIN is the
primary precursor of prostate cancer. The HGPIN in C3(1)Tag male mice prog-
resses to prostate carcinoma by 28 weeks (14). The 40-week time point therefore
ensures advanced disease progression and provides for adequate time for inter-
vention in our prevention study. After macroscopic evaluation during necropsy,
the genitourinary (GU) apparatus [consisting of the anterior prostate, dorsolateral
prostate (DL), ventral prostate, seminal vesicle, bladder, proximal ductal defer-
ence and proximal urethra] was dissected and weighed to assess the effect of diet
on GU weight. The anterior prostate, ventral prostate and DL prostate lobes were
dissected from the GU apparatus with the aid of a dissecting microscope and
weighed to assess the effect of diet on prostate weight. GU apparatus were fixed
in phosphate-buffered 10% paraformaldehyde for 4 h and transferred to 70%
ethanol until ready for histopathological analyses. Mouse inguinal fat, liver and
prostate were collected and stored at 80C for other analyses.
Blood collection
Blood (600 ll) was collected from each animal into ethylenediaminetetra-
acetic acid vials by cardiac puncture at necropsy to assess testosterone and
estrogen levels. Plasma was separated from blood samples by centrifugation
and stored at 80C until assayed.
Plasma measures
Total testosterone and estrogen were measured from plasma obtained from
individual mice from CO–CO and CO-FS groups at 24 and 40 weeks, using
the Testosterone EIA Kit or Estradiol EIA Kit respectively (Cayman Chemical
Company, Ann Arbor, MI). Measurements were done in triplicate following
the protocol provided in the kit.
Histopathological assessment
To assess cancer progression due to diet, GU apparatus previously fixed in
paraformaldehyde and thereafter in ethanol were sent to the Rodent Histopa-
thology Core of Dana-Farber/Harvard Cancer Center for processing and pa-
thology diagnosis. Briefly, the prostatic complex (consisting of all prostate
lobes) separated from each GU apparatus was paraffin embedded, sectioned
on a slide (six sections per slide) and stained with hematoxylin and eosin. The
animal identities were coded to avoid observer bias in the pathological
diagnosis. Two independent evaluators analyzed all specimens. Observations
were done for the presence and degree of epithelial hyperplasia and the pres-
ence of nuclear atypia in the epithelial cells in dorsalateral lobes of the prostate.
Specimens with nuclear atypia were classified as low-grade prostatic intra-
epithelial neoplasia (LGPIN) or HGPIN lesions following the guideline estab-
lished by the Mouse Models of Human Cancer Consortium Prostate cancer
Committee (17). Scores from two evaluators were averaged.
Fatty acid composition analysis
The fatty acid compositions of prostate, liver and fat at 24 weeks were ana-
lyzed by gas chromatography. Extraction of fatty acids was done as described
previously (16). Fatty acids suspended in iso-octane were separated and
identified using a PerkinElmer Clarus 500 Gas Chromatography (Shelton,
CT) with a Elite MWAX 30 m  0.53 mm  1.0 lm cross-linked polyethylene
glycol Capillary Column, in the following conditions: 220C for 100 min,
injector and flame ion detector at 240C, helium carrier gas flow rate of
2.0 ml/min. Peak identification was done using a customized standard (GLC
#704) (Nu-Chek-Prep, Elysian, MN), which contains 10 fatty acids as methyl
esters of stearate, oleate, linoleate, alpha linolenate, gamma linolenate, homo-
gamma linolenate, arachidonate, eicosapentaenoate, docosapentaenoate and
docosahexaenoate. Fatty acid methyl esters were estimated as the percentage
of the methylated fatty acids (area under the curve).
Gene expression RT2 PCR assay
Gene expression analysis of DL tissues from 24 weeks old mice consuming
either high x-3 or high x-6 diets (three tissues per group) was done, using
the Mouse Signal Transduction Pathway FinderTM RT2 profilerTM PCR Array
(PAMM-014) (SuperArray Bioscience Corporation, Frederick, MD). This ar-
ray was chosen to identify genes in signal transduction pathways that are
influenced by high x-3 fat diet and that may be applicable to cancer develop-
ment. Briefly, DL prostate was dissected in RNA stabilization reagent (Omega
Bio-tek, Norcross, GA) and frozen at80C until ready to use. Total RNA was
isolated from frozen DL prostate tissue with RNeasy Fibrous Tissue Mini Kit
(Qiagen, Valencia, CA), according to the manufacturer protocol. RNA yield,
purity and integrity were determined using an Agilent 2100 Bioanalyzer (Santa
Clara, CA). Further quality control was performed on all RNA samples with
the RT2 RNA QC PCR Arrays (SuperArray Bioscience Corporation). Comple-
mentary DNA was prepared from RNA using RT2 First Strand Kit and ampli-
fied by real time PCR using SuperArray RT2 qPCR Master Mix on ABI Prism
700 (Applied Biosystems), following the protocol provided by the manufac-
turer. Differential gene expression and statistical analysis of data were done
using the SuperArray software.
Immunoblot analysis
Frozen DL prostate tissues (three to four per group) were homogenized in
Tri Reagent (Sigma–Aldrich, St Louis, MO), followed by protein extraction
according to protocol from the manufacturer. Protein concentration was de-
termined by BCA protein assay kit (EMD Biosciences. Darmstad, Germany).
Fifteen micrograms of protein were loaded onto a 4–20% Tris–HCl polyacryl-
amide gradient gel (Bio-Rad Laboratories, Hercules, CA), separated by electro-
phoresis and transferred onto a nitrocellulose membrane. Blots were blocked
using 5% bovine serum albumin in Tris-Buffered Saline Tween-20 for 1 h at
room temperature and thereafter probed with primary antibodies in blocking
buffer overnight at 4C against: inhibitor of NF-kappa-B kinase beta (IKKb),
B-cell leukemia/lymphoma 2 (BCL2) (Cell Signaling Technology); Nitric ox-
ide synthase (NOS2) Type II (BD Biosciences), nuclear factor-kappaB (NF-
jB, p65) (Santa Cruz Biotechnology) or NF-jB inhibitor alpha (IKa) (Abcam)
for 1 h at room temperature. Beta-actin (Santa Cruz Biotechnology) was used
to normalize protein loading. Membrane was then incubated with either horse-
radish peroxidase conjugated antimouse (Santa Cruz Biotechnology) or anti-
rabbit (PIERCE) secondary antibody as appropriate. A Chemiluminescence
ECL Kit (PIERCE) was used for band detection. Densitometric analyses were
carried out using ChemDoc XRS system (Bio-Rad Laboratories) to acquire the
image, followed by image analysis with ‘Quantity One’ software, V.4.5.2 (Bio-
Rad Laboratories).
Immunohistochemistry
Expressions of androgen receptor (AR) and proliferating cell nuclear antigen
(PCNA) were assessed in mouse DL prostate by immunohistochemistry. Par-
affin sections of DL prostate (six sections per slide) were deparaffinized in
xylene, hydrated in a series of graded ethanol and rinsed in distilled water.
Antigen retrieval was done in a microwave oven using Vector Antigen
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Unmasking solution (Vector Laboratories, Burlingame, CA). This was fol-
lowed by blocking endogenous peroxidase activity using 3% hydrogen perox-
ide and Avidin/Biotin activity using Vector Avidin/Biotin blocking kit (Vector
Laboratories) following the manufacturers protocols. After blocking, sections
were treated with rabbit anti-AR (PG21; (Millipore, Temecula, CA) or mouse
anti-PCNA (Biogenex, San Ramon, CA) and thereafter with secondary anti-
bodies and vectastain Elite ABC kit (Vector Laboratories) for rabbit antibody
or Vector M.O.M kit (Vector Laboratories) for mouse primary antibodies.
Sections were incubated with 3, 3#-diaminobenzidine (Vector Laboratories)
and counterstained using hematoxylin. The levels of proliferation or AR ex-
pression were compared between the two diet groups by counting the number
of cells with PCNA or AR positively stained nucleus, respectively, per 1000
cells within viable areas of lesions. Apoptosis was assayed by morphological
identification (nuclear and cellular condensation, fragmentation of nuclei and/
or membrane blebbing and fragmentation of the cell into apoptotic bodies) of
apoptotic cells (18). The numbers of cells undergoing apoptosis based on
morphological indicators in 1000 epithelial cells of viable areas of lesions
were counted to estimate an apoptotic index.
Statistics
Western blot protein expression levels, apoptosis, AR and PCNA levels, fatty
acid composition, mean body weight gain, prostate and GU weight between
diet groups and across time, were statistically analyzed by t-test. Testosterone
and estradiol levels between diet groups and across time were analyzed by
Mann–Whitney test. The differences in prostate lesion incidence between diet
groups were assessed by Fisher’s exact test. All statistical tests were performed
using Prism software.
Results
Effect of diets on tissue lipid composition
The lipid composition of the prostate, liver and fat at 24 weeks of age
were analyzed. Mice at this age consumed either high x-3 diet or high
x-6 diet. As expected, the lipid composition of tissues reflected the
lipid content of the diet (Supplementary Figure 1 is available at Car-
cinogenesis Online). The prostate, liver and fat of mice that consumed
high x-6 diet contained significantly more (by t-test at P , 0.05) LA
than the prostate, liver and fat of mice that consumed high x-3 diet.
AA was significantly more (by t-test at P , 0.05) in the liver and
prostate but not in the fat of mice that consumed the high x-6 diet than
mice that consumed high x-3 diet. The liver, prostate and fat of mice
that consumed the high x-3 diet contained significantly more (by
t-test at P, 0.05) ALA, EPA and DHA than the liver, fat and prostate
of mice that consumed high x-6 diet.
Effect of diets on body weight gain
To assess the effect of diet on body weight of mice, we weighed the
mice weekly from the time of weaning to time of killing (40 weeks).
Fig. 1. Effect of diets on average body weight gain, prostate weight and GU weight between CO–CO and CO-FS mice. (A) Average body weight gain. Data are from
measurements of body weight gain for individual mouse from the time of weaning to 40 weeks of age. Analysis by t-test showed no significant difference in body
weight gain between the two groups at P, 0.05. n5 9/group. Bar is mean of body weight gain per week. (B) Prostate weight at 24 and 40 weeks of age. Mouse DL,
anterior prostate and ventral prostate lobes were dissected and weighed, and the sums were expressed as milligrams per 25 grams body weight. The average weight
was significantly different between the two groups at 24 weeks (n5 15–19/group) and 40 weeks (n 5 12/group) by t-test and at P, 0.05. Average prostate weight
significantly increased in both groups with time by t-test at P, 0.05. C and D) GU weight at 24 and 40 weeks of age. Mouse GU were dissected at euthanasia and
weighed. The weights were expressed as milligrams per 25 grams body weight. The average GU weight was not significantly different between the two groups at 24
weeks but significantly lower at 40 weeks in the CO-FS group than in the CO–CO group by t-test and at P , 0.05 (n 5 19/group). Average GU weight increased
significantly in CO–CO group with time. Significantly different between groups, ysignificantly different across time at P , 0.05. Arrow bars represent SEM.
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Control and test diets were designed to be nutritionally balanced and
with the same percentage of energy from fat. There was no significant
difference in body weight gain between mice consuming high x-6
control diet (CO–CO group) and mice consuming high x-3 test diet
(CO-FS group) (Figure 1A).
Effect of diets on prostate weight and GU weight
We assessed the effect of diet on prostate and GU weights as an
indicator of progression of prostate tumorigenesis. Two time points,
24 and 40 weeks, were considered for assessment of disease progres-
sion. The prostate of mice consuming the high x-3 diet weighed
significantly less than prostate of mice consuming the high x-6 diet
at 24 and 40 weeks (by t-test at P , 0.05) (Figure 1B). Mice that
consumed high x-3 diet had an increase of 10.21 mg in prostate
weight between 24 and 40 weeks, whereas mice that consumed high
x-6 diet had an increase of 22.49 mg. Diet did not affect the GU
weight significantly at 24 weeks (Figure 1C and D). The gross ap-
pearance of the GU apparatus (Figure 1C) was similar between the
two diet groups at 24 weeks. In contrast, the gross appearance of the
GU apparatus of mice that consumed high x-3 diet appeared smaller
and the average weight was significantly lower than GU apparatus of
mice consuming high x-6 diet at 40 weeks (Figure 1D).
Effect of diets on prostate histopathology
The histology of the prostate in C3(1) Tag mice of various ages has
previously been documented, and it is known that on a usual diet,
mice develop HGPIN in the prostate beginning 20 weeks of age,
which subsequently progresses to adenocarcinoma (ADC) with
advancing age (14). DLs of C3(1) Tag mice were evaluated in
CO–CO and CO-FS groups at 24 and 40 weeks of age. The degree
and progression of epithelial hyperplasia and atypia were com-
pared between the two diet groups (Figure 2). There was a slower
progression of disease in mice consuming the high x-3 diet than in
mice consuming the high x-6 diet at each time point (Figure 2). At
24 weeks, there was a significantly low proportion of LGPIN in-
cidence (45% in CO–CO versus 64% in CO-FS) and significantly
high proportion of HGPIN incidence (55% in CO–CO versus 36%
in CO-FS) in CO–CO group compared with CO-FS group (by
Fischer’s exact test at P , 0.05). No ADCs were observed in mice
at 24 weeks. There was a significantly lower proportion of LGPIN
incidence and higher proportion of ADC incidence in CO–CO
group compared with CO-FS group at 40 weeks (by Fischer’s exact
test at P, 0.05). At 40 weeks, the CO–CO group had 18% LGPIN,
46% HGPIN and 36% ADC, whereas the CO-FS group had 36%
LGPIN, 46% HGPIN and 18% ADC.
Fig. 2. Effect of diets on the incidence of PIN and ADC lesions in the DL prostate. (A–D) Representative hematoxylin- and eosin-stained sections from 24 to
40 weeks old mice. A and C illustrate the presence of LGPIN and HGPIN and ADC lesions as demonstrated by epithelial cells proliferation, hyperchromasia,
nuclear enlargement and membrane irregularity. (B and D) Consumption of high x-3 diet resulted in marked reduction of epithelial cells proliferation,
hyperchromasia, nuclear enlargement and membrane irregularity. (E) Incidence of PIN lesions and ADC in CO–CO and CO-FS groups at 24 and 40 weeks of age.
Prostate specimens were histologically examined for lesions by two independent evaluators and scores were averaged (n 5 11–12/group). Pictures were taken at
40 magnification (Star indicates LGPIN; arrow indicates HGPIN; arrow head indicates ADC.  , y, z represent significant difference in LGPIN, HGPIN and ADC,
respectively, between CO–CO and CO-FS group at P , 0.05).
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Effect of diets on plasma estrogen and testosterone levels and
expression of AR
Plasma testosterone and estradiol levels were measured by enzyme
immunoassays. Testosterone levels were not significantly different
due to age or diet (Figure 3A). To further test the effect of diet on
testosterone action, AR expression in the DL was analyzed by immu-
nohistochemistry. The expression level of AR in DL was significantly
higher in mice consuming the high x-6 diet than in mice consuming
the high x-3 diet at 40 weeks but not at 24 weeks (Figure 3B). There
were significant differences in the levels of estradiol in mice consum-
ing high x-6 diet compared with mice consuming high x-3 diet at 24
and 40 weeks of age (Figure 3C). Estradiol level was significantly
increased in mice that consumed high x-3 diet compared with mice
that consumed high x-6 diet at 24 weeks. However, at 40 weeks,
estradiol level was significantly less in mice that consumed high
x-3 diet (10.45 pg/ml) compared with mice that consumed high
x-6 diet (15.89 pg/ml). Consumption of high x-3 diet resulted in a
significant decrease in estradiol level as mice progressed in age,
whereas consumption of high x-6 diet resulted in slight increase in
estradiol level as mice progressed in age.
Effect of diets on gene and protein expression in the DL prostate at
24 weeks of age
To investigate the molecular mechanism by which high x-3 diet may
be slowing down the progression of prostate tumorigenesis in the DL
prostate, we analyzed the expression of several genes involved in
signal transduction pathways. We chose the 24 weeks time point
because mice are in the early stages of prostate carcinogenesis, there-
fore gene expression difference due to the diet and not to the tumor
Fig. 3. Effect of diets on plasma testosterone and estradiol levels. Mice from
both diet groups were killed at 24 and 40 weeks of age. Plasma was obtained
for individual assay from blood collected from mice. (A) The level of
testosterone was slightly less in mice from CO-FS group than mice from CO–
CO group at 24 and 40 weeks (n 5 12–19/group) and increased slightly as
mice progressed in age in the CO–CO group (Mann–Whitney test at
P, 0.05). (B) Expression of AR was lower significantly in the CO-FS group
than the CO–CO group at 40 weeks by t-test, n 5 5/group. A total of 1000
epithelial cells within viable areas of lesions per slide were counted for AR
expression assay. (C) Estradiol levels were significantly different between
the two groups at 24 and 40 weeks by Mann–Whitney test at P , 0.05
(n5 15–20/group). Estradiol level increased slightly as mice progressed in
age in CO–CO group. Estradiol level was significantly less in CO-FS group
than CO–CO group at 40 weeks and decreased significantly as mice
progressed in age in CO-FS group. Significantly different at P , 0.05,
ysignificantly different across time at P , 0.05. Arrow bars represent SEM.
Table I. Gene expression in DL at 24 weeks of age
Gene name Symbol Fold
difference
CO-FS versus
CO–CO
Activating transcription factor 2 Atf2 4.91
Ornithine decarboxylase, structural 1 Odc1 2.19
Etoposide induced 2.4 mRNA Ei24 3.91
Cyclin-dependent kinase 2 Cdk2 2.37
Glycogen synthase 1, muscle Gys1 2.11
Hexokinase 2 Hk2 2.25
Jun oncogene Jun 2.54
B-cell leukemia/lymphoma 2 Bcl2 9.94
Bone morphogenetic protein 2 Bmp2 2.81
Chemokine (C-C motif) ligand 2 Ccl2 3.56
Chemokine (C-X-C motif) ligand 9 Cxcl9 3.64
Cytochrome P450, family 19, subfamily a,
polypeptide 1
Cyp19a1 2.26
Early growth response 1 Egr1 2.45
Engrailed 1 En1 3.18
Fas ligand (TNF superfamily, member 6) Fasl 2.98
Fatty acid synthase Fasn 2.15
Fibroblast growth factor 4 Fgf4 4.44
Forkhead box A2 Foxa2 3.87
Homeo box A1 Hoxa1 3.31
Insulin-like growth factor binding protein 3 Igfbp3 2.15
Interleukin 1 alpha Il1a 21.61
Lymphoid enhancer binding factor 1 Lef1 3.1
Matrix metallopeptidase 10 Mmp10 2.5
Peroxisome proliferator activated receptor gamma Pparg 7.6
Retinol binding protein 1, cellular Rbp1 2.08
Transcription factor 7, T-cell specific Tcf7 2.51
Telomerase reverse transcriptase Tert 3.35
Prostate transmembrane protein, androgen induced 1 Pmepa1 3.41
Vascular cell adhesion molecule 1 Vcam1 2.35
WNT1 inducible signaling pathway protein 1 Wisp1 9.67
Wingless-related MMTV integration site 2 Wnt2 2.66
Mice were placed on either corn oil diet or transferred to fish oil diet at 7
weeks of age. Gene expression in the DL prostate of mice at 24 weeks of age
was performed by real time reverse transcriptase. Genes with .2-fold
differences in mRNA expression are shown. Results are from three replicates
for each group.
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can be assessed. A total of 84 genes was quantitatively assayed using
the Mouse Signal Transduction Pathway FinderTM RT2 profilerTM
PCR Array. Table I presents 31 genes with.2-fold differences (using
SuperArray statistical analyses software) between CO-FS and CO–
CO group at 24 weeks of age. We further analyzed the genes using the
Ingenuity Systems software (IPA 8.0), and this showed that a number
of the altered genes are associated with NF-jB and apoptosis path-
ways (data not shown). We chose NF-jB inhibitor alpha (IKa), IkB
kinase beta (IKKb), NF-jBp65 and NOS2 from NF-jB pathway and
B-cell leukemia/lymphoma 2 (BCL2) from apoptosis pathway for
Western blot analysis. Western blot results showed the expressions
of Ika protein (Figure 4A) to be slightly higher and BCL2 protein
(Figure 4B) to be significantly lower due to consumption of high x-3
diet. Expressions of NF-jBp65, IKKb and NOS2 proteins were sig-
nificantly lower due to consumption of high x-3 diet (Figure 4A).
Effect of diets on cell proliferation and apoptosis in the DLs
We further tested the molecular mechanism by which diet may be
influencing the progression of prostate tumorigenesis by comparing
the proliferation and apoptosis in the areas of lesions in DL prostate
of mice from the two groups. Proliferation was significantly lower
(Figure 5E) and apoptosis was significantly higher (Figure 5J) in
prostate epithelial cells in mice that consumed high x-3 diet com-
pared with mice that consumed high x-6 diet.
Discussion
One obvious characteristic of the Western diet is the high intake of
high x-6 fat, which has been associated with high prostate cancer risk
in epidemiologic studies (19–21). These studies also suggest that
Fig. 4. Effect of diets on proteins in NF-jB and apoptosis pathways in DL prostate. (A) Protein expression of NF-jBp65, IKa, IKKb and NOS2 in the DL prostate
and their corresponding densitometric analyses in 24 weeks old mice. Expression of IKa protein was slightly higher, whereas the expressions of NF-jBp65, IKKb
and NOS2 proteins were significantly lower in DL prostate of mice that consumed high x-3 fat diet than mice that consumed high x-6 fat diet. (B) Protein
expression of BCL2 in the DL prostate and the densitometric analysis in 24 weeks old mice. Expression of BCL2 protein was lower significantly in the DL prostate
of mice that consumed high x-3 fat diet compared with mice that consumed high x-6 fat diet. Equal loading of protein in the lanes was confirmed by b-actin.
Values are relative density corrected for b-actin. Significantly different at P , 0.05, n 5 3–5/group. Arrow bars represent SD or SEM where applicable.
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consumption of fish or fish oil, which are very high in x-3 fatty acids,
may reduce prostate cancer risk (10,21). We investigated the role of
high x-3/x-6 diet in the prevention of prostate cancer risk and the
molecular mechanism, which might be involved. The 24 and 40 weeks
intervention time points were chosen as adequate time for early-stage
disease progression and advanced disease progression since studies
indicate that C3(1)Tag male mice on a usual diet develop HGPIN
beginning 20 weeks and progresses to prostate carcinoma from
28 weeks (14,22). We chose the C3(1) Tag model for this study for its
well characterized disease progression from normal to PIN to ADC (14).
A switch from high x-6 diet to a high x-3 diet at postpuberty was
chosen for this study because adults are able to make diet choices.
Postpuberty consumption of high x-3 fat diet significantly slowed
down the progression of prostate tumorigenesis in mice as observed
Fig. 5. Effect of diets on the extent of proliferation and apoptosis in DL prostate. DL prostate sections from the two groups were assessed for proliferation by
immunohistochemistry analysis of PCNA at 24 and 40 weeks (A–D). Proliferation was significantly less in mice that consumed high x-3 diet compared with mice
that consumed high x-6 diet by t-test at P, 0.05 (E). Apoptosis was assessed by morphological identification of apoptotic cells in hematoxylin- and eosin-stained
sections (F–I) and was significantly greater in mice that consumed high x-3 diet compared with mice that consumed high x-6 diet by t-test at P, 0.05 (J). A total
of 1000 epithelial cells within viable areas of lesions per slide were counted for proliferation and apoptosis assays. n5 5/group for proliferation assay, n5 7/group
for apoptosis assay. Pictures were taken at 40 magnification. Arrow indicates apoptotic cells. Arrow bars represent SEM. Significantly different at P , 0.05.
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by the slowed development of high-grade prostate lesions in mice that
consumed high x-3 diet compared with mice that consumed high x-6
diet. The ability of high x-3 diet to slow promotion of tumorigenesis
in our mouse model was also observed as less GU and prostate
weights in mice that consumed high x-3 diet. At the molecular level,
mice that consumed high x-3 diet showed greater apoptosis and less
proliferation in epithelial cells of the prostate as confirmed by less
expression of the antiapoptotic gene BCL2 at messenger RNA and
protein levels and less staining for PCNA compared with mice that
consumed high x-6 diet. The EPA and DHA in the high x-3 diet were
accumulated in the prostate of mice that consumed high x-3 diet,
which likely induced suppression of disease progression. This is sup-
ported by Rose et al. (7), indicating that EPA and DHA suppress
proliferation and promote apoptosis in prostate cancer cells.
To identify the underlying molecular factors by which high x-3 diet
may be slowing down the progression of prostate tumorigenesis, we
analyzed for the expression of some genes involved in NF-jB path-
way because further analysis of the gene array into pathway-focused
array (IPA 8.0) showed the NF-jB pathway to be differentially acti-
vated. NF-jB is a key mediator of survival, and is upregulated during
prostate cancer progression (23,24). NF-jB is complexed with the
inhibitor of NF-jB (IK) in the cytosol. When activated, the inhibitor
of NF-jB kinase (IKK) phosphorylates the IK protein, resulting in the
dissociation of IK from NF-jB. The activated NF-jB is then trans-
located into the nucleus to regulate the expression of downstream
genes. The expression of IK was slightly higher and the expression
of IKK was significantly lower in mice that consumed high x-3 fat
diet as shown in the Western blot results (Figure 4A). The messenger
RNA expression fold for IK and IKK was 1.2 and 1.97 (CO-FS
versus CO–CO), respectively. The expressions of NF-jBp65 subunit
and NOS2, a downstream gene in the NF-jB pathway, were signifi-
cantly less in mice that consumed high x-3 fat diet. NOS2 is highly
expressed in prostate tumors (25).
We also investigated the effect that high x-3 diet may have on
testosterone and estradiol levels in circulation. Testosterone has been
vigorously studied because of its role in promoting prostate cancer,
but the role of estrogen in prostate disease process has received very
little attention despite reports that estrogen may promote prostate
tumorigenesis (26–29). Serum testosterone level declines in the aging
male, whereas estrogen level increases and remains constant (30,31).
However, rising estradiol levels may increase prostate sensitivity to
testosterone via upregulation of AR (32,33). We showed that con-
sumption of high x-3 diet resulted in significantly lower estradiol
level at 40 weeks and slightly lower testosterone level with a concom-
itant significant decrease in the expression level of AR at 40 weeks,
suggesting a decrease in androgen stimulation due to consumption of
high x-3 diet.
We conclude that high x-3 diet slowed prostate tumorigenesis in
C3(1) Tag mouse model, and the mechanisms involved are due to
lower levels of testosterone and estradiol resulting in lower expression
of AR and less expressions of genes in the NF-jB and the antiapop-
totic BCL2 pathways. These molecular changes suppressed prolifer-
ation and promote apoptosis in the epithelial cells in areas of lesions
in mouse dorsalateral prostate. By extrapolation of our findings to
humans, a dietary change by humans that involves consumption of
more x-3 fat such as obtained from fish and fish oil, instead of corn oil
with little or no x-3 fat, may be helpful in the suppression and pre-
vention of prostate cancer risk, especially for those who are at the high
risk of developing the disease.
Supplementary material
Supplementary Tables I and II and Figure 1 can be found at http://
carcin.oxfordjournals.org.
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